Skip to content
Search
Please enter at least 3 characters.

Latest Stories

RPS Scotland expects all patient-facing pharmacists to be independent prescribers by 2030

The Royal Pharmaceutical Society (RPS) in Scotland expects all pharmacists in a patient-facing role to become independent prescribers by 2030.

In a report published on Wednesday (February 2), the RPS outlined the vision for pharmacy in 2030, forecasting the “traditional boundaries between pharmacy sectors will be broken down” by then.


It said that by 2030, pharmacy teams will work together, using their expertise and making the best use of medicine to deliver “seamless care for patients.”

Clare Morrison, director for Scotland at RPS, said: “In our vision, pharmacists will be recognised as medicines experts who take leadership of prescribing in all care settings and optimise therapeutic outcomes for patients. This means prescribing, monitoring, reviewing, adjusting and stopping medicines, underpinned by empowering patients to make shared decisions.”

The report, jointly published by RPS Scotland and the National Pharmacy Technician Group Scotland (NPTGS), covers the vision co-produced with pharmacists and pharmacy technicians working in all healthcare settings across Scotland, including community pharmacy, hospitals and GP practices.

Melanie Bryan, chair of NPTGS, said: “The vision sets out that in 2030, pharmacy technicians will lead medicines management processes, both in technical roles focused on safe and efficient supply of medicines, and in patient-focused roles to support patients’ use of medicines.”

The vision describes that having the right skill mix in pharmacy teams through robust workforce planning will be crucial for both increasing capacity of teams and improving patient care.

RPS will use the vision to communicate with partners across NHS, Scottish government and Holyrood about initiatives that are needed to maximise the potential of pharmacy across the health and social care system.

Besides, RPS has called for the introduction of a single shared electronic patient record across all health and care services, which would release clinicians’ capacity, improve safety and ensure better care for patients.

Commenting on the report, Andrew Carruthers, chair of the Scottish Pharmacy Board, said: “Pharmacy teams already make a huge contribution to people every day, and a spotlight was shone on their vital work during the pandemic. However, we also know that pharmacy has the potential to achieve so much more, and publishing Pharmacy 2030 is the first step on our journey to achieving this.

“By working with partners across health and social care, we will ensure pharmacy continues to deliver improved health outcomes for people, across all care settings, long into the future.”

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less